Multinational cost-utility analysis of panel-based pharmacogenetics-guided treatment of patients enrolled in the U-PGx PREPARE study.
- DOI
- 10.1016/j.eclinm.2025.103686
- Published
- 2026 Jan
- Container
- EClinicalMedicine
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.eclinm.2025.103686,
title = {Multinational cost-utility analysis of panel-based pharmacogenetics-guided treatment of patients enrolled in the U-PGx PREPARE study.},
author = {Fragoulakis V and Swen JJ and Koufaki MI and Blagec K and Blagus T and Böhringer S and Cambon-Thomsen A and Cecchin E and Cheung KC and Deneer VHM and Dupui M and Jonsson S and Joefield-Roka C and Just KS and Karlsson MO and Konta L and Koopmann R and Kriek M and Lehr T and Manson LEN and Rial-Sebbag E and Rollinson V and Roncato R and Samwald M and Schaeffeler E and Skokou M and Schwab M and Steinberger D and Stingl JC and Tremmel R and Turner RM and van Rhenen MH and van der Wouden CH and Dávila-Fajardo CL and Dolžan V and Pirmohamed M and Sunder-Plassmann G and Toffoli G and Guchelaar HJ and Patrinos GP and Mitropoulou C},
year = {2026},
journal = {EClinicalMedicine},
doi = {10.1016/j.eclinm.2025.103686},
url = {https://doi.org/10.1016/j.eclinm.2025.103686}
}RIS
TY - JOUR TI - Multinational cost-utility analysis of panel-based pharmacogenetics-guided treatment of patients enrolled in the U-PGx PREPARE study. AU - Fragoulakis V AU - Swen JJ AU - Koufaki MI AU - Blagec K AU - Blagus T AU - Böhringer S AU - Cambon-Thomsen A AU - Cecchin E AU - Cheung KC AU - Deneer VHM AU - Dupui M AU - Jonsson S AU - Joefield-Roka C AU - Just KS AU - Karlsson MO AU - Konta L AU - Koopmann R AU - Kriek M AU - Lehr T AU - Manson LEN AU - Rial-Sebbag E AU - Rollinson V AU - Roncato R AU - Samwald M AU - Schaeffeler E AU - Skokou M AU - Schwab M AU - Steinberger D AU - Stingl JC AU - Tremmel R AU - Turner RM AU - van Rhenen MH AU - van der Wouden CH AU - Dávila-Fajardo CL AU - Dolžan V AU - Pirmohamed M AU - Sunder-Plassmann G AU - Toffoli G AU - Guchelaar HJ AU - Patrinos GP AU - Mitropoulou C PY - 2026 JO - EClinicalMedicine DO - 10.1016/j.eclinm.2025.103686 UR - https://doi.org/10.1016/j.eclinm.2025.103686 ER -
APA
V, F., JJ, S., MI, K., K, B., T, B., S, B., A, C., E, C., KC, C., VHM, D., M, D., S, J., C, J., KS, J., MO, K., L, K., R, K., M, K., T, L., LEN, M., E, R., V, R., R, R., M, S., E, S., M, S., M, S., D, S., JC, S., R, T., RM, T., MH, V. R., CH, V. D. W., CL, D., V, D., M, P., G, S., G, T., HJ, G., GP, P., & C, M. (2026). Multinational cost-utility analysis of panel-based pharmacogenetics-guided treatment of patients enrolled in the U-PGx PREPARE study.. EClinicalMedicine. https://doi.org/10.1016/j.eclinm.2025.103686
Source records
- pubmed · retrieved 2026-09-26T03:02:26.693Z